Research Corporation Technologies


Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Research Corporation Technologies

Research Corporation Technologies

6440 N. Swan Road, Suite 200, Tucson, AZ 85718


What We Do

RCT provides venture capital to start-up or early-stage companies with technologies that have the potential to become significant biomedical products.

RCT licenses new, promising biomedical technologies and products to industry, offering innovators the experience, expertise, and funding required for success.

Through programs like the MedTech Innovator competition, RCT offers mentorship and strategic guidance to early-stage medical device companies.



Portfolio

Biolog acquired Anaerobe Systems, expanding its capabilities in microbial identification services.

#Microbial and Phenotypic Profiling

Secured over $10 million in financing led by RCT.

#Pharmaceuticals

Expanded product portfolio with $9M Series B financing.

#Genomics

Combining high-throughput microfluidics and advanced analytics to unlock mass spectrometry.

#Biologics, Cell and Gene Therapies

NanoEX is a next-gen exosome isolation platform.

#Exosome Isolation

Smart nanoparticle platform for a unified next-gen multiomic workflow.

#Nanoparticle Technology


Key People

President, Medical Devices & Chief Financial Officer

President, Biotechnologies

Chief Executive Officer, MedTech Innovator